EC Number | Cloned (Comment) | Organism |
---|---|---|
2.7.7.15 | expression in COS-1 cells, which have very low endogenous CTP:phosphocholine cytidylyltransferase activity | Homo sapiens |
EC Number | Protein Variants | Comment | Organism |
---|---|---|---|
2.7.7.15 | A93T | moderate solubility, but impaired catalytic activity and thermal destabilization. Mutation causes retinal dystrophy | Homo sapiens |
2.7.7.15 | A99T | moderate solubility, but impaired catalytic activity and thermal destabilization. Mutation causes spondylometaphyseal dysplasia | Homo sapiens |
2.7.7.15 | A99V | moderate solubility, but impaired catalytic activity and thermal destabilization. Mutation causes spondylometaphyseal dysplasia | Homo sapiens |
2.7.7.15 | E129K | moderate solubility, but impaired catalytic activity and thermal destabilization. Mutation causes spondylometaphyseal dysplasia | Homo sapiens |
2.7.7.15 | E280del | a single amino acid deletion in the autoinhibitory helix increases the constitutive (lipid-independent) enzyme activity x024fold. E280del enhances the response of the enzyme to anionic lipid vesicles 4fold. Mutation causes lipodystrophy in heterozygous status. Mutation causes lipodystrophy | Homo sapiens |
2.7.7.15 | F191L | severely reduced expression levels, suggesting aggregation and potential degradation of misfolded protein. Mutation causes spondylometaphyseal dysplasia | Homo sapiens |
2.7.7.15 | P150A | missense variant in the catalytic domain, low solubility linked to reduced activity in cell lysates, consistent with aberrant folding and aggregation. Mutation causes spondylometaphyseal dysplasia with cone-rod dystrophy | Homo sapiens |
2.7.7.15 | R223S | mutation in a signal-transducing linker between the catalytic and membrane-binding domains, impaired enzymatic activity without fold-destabilization. Mutation causes spondylometaphyseal dysplasia | Homo sapiens |
2.7.7.15 | R283stop | severely reduced expression levels, suggesting aggregation and potential degradation of misfolded protein. Mutation causes spondylometaphyseal dysplasia | Homo sapiens |
2.7.7.15 | S114T | severely reduced expression levels, suggesting aggregation and potential degradation of misfolded protein. Mutation causes spondylometaphyseal dysplasia | Homo sapiens |
2.7.7.15 | S333L.fs164 | severely reduced expression levels, suggesting aggregation and potential degradation of misfolded protein. Mutation causes lipodystrophy | Homo sapiens |
2.7.7.15 | V142M | missense variant in the catalytic domain, low solubility linked to reduced activity in cell lysates, consistent with aberrant folding and aggregation. Mutation causes lipodystrophy in heterozygous status | Homo sapiens |
EC Number | Natural Substrates | Organism | Comment (Nat. Sub.) | Natural Products | Comment (Nat. Pro.) | Rev. | Reac. |
---|---|---|---|---|---|---|---|
2.7.7.15 | CTP + phosphocholine | Homo sapiens | - |
diphosphate + CDP-choline | - |
? |
EC Number | Organism | UniProt | Comment | Textmining |
---|---|---|---|---|
2.7.7.15 | Homo sapiens | P49585 | - |
- |
EC Number | Source Tissue | Comment | Organism | Textmining |
---|---|---|---|---|
2.7.7.15 | fibroblast | - |
Homo sapiens | - |
EC Number | Substrates | Comment Substrates | Organism | Products | Comment (Products) | Rev. | Reac. |
---|---|---|---|---|---|---|---|
2.7.7.15 | CTP + phosphocholine | - |
Homo sapiens | diphosphate + CDP-choline | - |
? |
EC Number | Synonyms | Comment | Organism |
---|---|---|---|
2.7.7.15 | CCTalpha | - |
Homo sapiens |
2.7.7.15 | CTP:phosphocholine cytidylyltransferase CCT | - |
Homo sapiens |
2.7.7.15 | PCYT1A | - |
Homo sapiens |
EC Number | Temperature Stability Minimum [°C] | Temperature Stability Maximum [°C] | Comment | Organism |
---|---|---|---|---|
2.7.7.15 | 47.5 | - |
Tm-value for mutant enzyme A99T | Homo sapiens |
2.7.7.15 | 48.7 | - |
Tm-value for mutant enzyme E129K | Homo sapiens |
2.7.7.15 | 49.5 | - |
Tm-value for mutant enzyme A93T | Homo sapiens |
2.7.7.15 | 50.3 | - |
Tm-value for mutant enzyme A99V | Homo sapiens |
2.7.7.15 | 50.7 | - |
Tm-value for mutant enzyme E280del | Homo sapiens |
2.7.7.15 | 54.5 | - |
Tm-value for wild-type enzyme isolated from the particulate fraction after denaturation and renaturation | Homo sapiens |
2.7.7.15 | 55 | - |
Tm-value for wild-type enzyme purified in native form from the soluble fraction of COS cells | Homo sapiens |
2.7.7.15 | 56.1 | - |
Tm-value for mutant enzyme Y240H | Homo sapiens |
2.7.7.15 | 57.1 | - |
Tm-value for mutant enzyme R223S | Homo sapiens |
EC Number | General Information | Comment | Organism |
---|---|---|---|
2.7.7.15 | malfunction | mutations in the gene encoding CTP:phosphocholine cytidylyltransferase (PCYT1A) cause three distinct pathologies in humans: lipodystrophy, spondylometaphyseal dysplasia with cone-rod dystrophy (SMD-CRD), and isolated retinal dystrophy | Homo sapiens |
2.7.7.15 | metabolism | CTP:phosphocholine cytidylyltransferase is the key regulatory enzyme in phosphatidylcholine synthesis | Homo sapiens |